Dr. Grace Blest-Hopley is a Neuroscientist researching cannabinoids and psychedelics. Grace completed her Ph.D in Neuroscience at King's College London. She currently serves as the Chief Scientific Officer at NWPharma Tech and Research Director at Heroic Hearts Project, a charity that supports combat veterans with mental health challenges resulting from trauma. Grace is also the founder of Hystelica, a company advancing and advocating for understanding of safe and effective psychedelic use for women.